First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate. (10th May 2014) - Eskazan, Ahmet Emre; Ayer, Mesut; Kantarcioglu, Bulent; Arica, Deniz; Demirel, Naciye; Aydin, Demet; Yalniz, Fevzi Firat; Elverdi, Tugrul; Salihoglu, Ayse; Ar, Muhlis Cem; Ongoren Aydin, Seniz; Baslar, Zafer; et al.